arrow
D

Daniel Lin

Fred Hutchinson Cancer Center
H指数:22
被引数:2,819

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with “quadruple wild-type” (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated

NSABP FC-11:一项基于HER2状态(扩增、非扩增[野生型]或突变)的尼拉替尼联合曲妥珠单抗或尼拉替尼联合西妥昔单抗治疗“四重野生型”(KRAS/NRAS/BRAF/PIK3CA)转移性结直肠癌的II期研究

2025-08-090
PRE
A comprehensive spatial atlas of neoadjuvant chemoradiation therapy in resected pancreatic cancer identifies cellular & microenvironmental determinants of persister populations
2024-09-150
PRE
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer

使用方案指导的前列腺癌主动监测的患者的长期结果

2024-06-255
OA
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage
2024-06-033
PRE
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

通过多祖先全基因组发现187种新的风险变异来表征前列腺癌风险

2023-11-0928
OA
HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development
2023-03-2914
OAAI
Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer
2022-08-0112
OAAI
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment

基质细胞HIF2调节胰腺癌微环境中的免疫抑制

2022-06-0186
OAAI
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

前列腺癌的跨祖先全基因组关联荟萃分析确定了新的易感位点并为遗传风险预测提供了信息

2021-01-04287
OAAI